Key result
Healthy human aortic valves express laminin isoforms LN-411, LN-421, LN-511, and LN-521, and a modified decellularization protocol reduced DNA content to 6.1% of normal controls while preserving the basement membrane.
Why the study?
In-depth knowledge of native heart valve microstructure is lacking and the basement membrane remains incompletely characterized, challenging the development of tissue-engineered valves.
Absolute Event Rate: 63.4% vs 1040%
p-value: p=0.0137
This study identifies specific laminin isoforms in human and rat aortic valves and demonstrates a decellularization protocol that preserves these basement membrane components while effectively removing cells and DNA, providing a scaffold for tissue engineering.
May guide laminin-preserving decellularization for valve scaffolds; leaves open clinical translation pending in vivo validation.
Aortic valve stenosis is one of the most common cardiovascular diseases in western countries and can only be treated by replacement with a prosthetic valve. Tissue engineering is an emerging and promising treatment option, but in-depth knowledge about the microstructure of native heart valves is lacking, making the development of tissue-engineered heart valves challenging. Specifically, the basement membrane (BM) of heart valves remains incompletely characterized, and decellularization protocols that preserve BM components are necessary to advance the field. This study aims to characterize laminin isoforms expressed in healthy human aortic valves and establish a small animal decellularized aortic valve scaffold for future studies of the BM in tissue engineering. Laminin isoforms were assessed by immunohistochemistry with antibodies specific for individual α, β, and γ chains. The results indicated that LN-411, LN-421, LN-511, and LN-521 are expressed in human aortic valves (n = 3), forming a continuous monolayer in the endothelial BM, whereas sparsely found in the interstitium. Similar results were seen in rat aortic valves (n = 3). Retention of laminin and other BM components, concomitantly with effective removal of cells and residual DNA, was achieved through 3 h exposure to 1% sodium dodecyl sulfate and 30 min exposure to 1% Triton X-100, followed by nuclease processing in rat aortic valves (n = 3). Our results provide crucial data on the microenvironment of valvular cells relevant for research in both tissue engineering and heart valve biology. We also describe a decellularized rat aortic valve scaffold useful for mechanistic studies on the role of the BM in heart valve regeneration.
No takes yet. Share an insight, caveat, or question.
Granath et al. (2020) studied Healthy aortic valves (n=3). Decellularization with SDS, Triton X-100, and benzonase endonuclease vs. Normal control aortic valves was evaluated on DNA content per aortic valve (p=0.0137). Healthy human aortic valves express laminin isoforms LN-411, LN-421, LN-511, and LN-521, and a modified decellularization protocol reduced DNA content to 6.1% of normal controls while preserving the basement membrane.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: